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Summary
GABAC () receptors are members of the Cys-loop su-
perfamily of neurotransmitter receptors, which in-
cludes nicotinic acetylcholine (nACh), 5-HT3, and gly-
cine receptors. As in other members of this family,
the agonist binding site of GABAC receptors is rich in
aromatic amino acids, but while other receptors bind
agonist through a cation- interaction to a trypto-
phan, the GABAC binding site has tyrosine at the
aligning positions. Incorporating a series of tyrosine
derivatives at position 198 using unnatural amino
acid mutagenesis reveals a clear correlation between
the cation- binding ability of the side chain and EC50
for receptor activation, thus demonstrating a cat-
ion- interaction between a tyrosine side chain and a
neurotransmitter. Comparisons among four homolo-
gous receptors show variations in cation- binding
energies that reflect the nature of the cationic center
of the agonist.
Introduction
GABA is the major inhibitory neurotransmitter of the
central nervous system, and there are three families of
GABA receptors [1]. While GABAB is a G protein-cou-
pled receptor, GABAA and GABAC receptors are homol-
ogous but distinct members of the Cys-loop superfam-
ily of ligand-gated ion channels, which also includes
nicotinic acetylcholine (nACh), 5-HT3 (serotonin), and
glycine receptors [2]. GABAC receptors are most closely
related to GABAA receptors, but they have distinct ki-
netic and pharmacological properties, including greater
sensitivity to GABA, and, unlike GABAA receptors, the
ability to function as homopentamers [3–5].
As in other members of the Cys-loop superfamily, the
proposed agonist binding region of the GABAC receptor
is rich in aromatic residues. These are associated with
several noncontiguous sequences in the extracellular
domain termed loops or binding segments A–F (Figure
1A). Figure 1B shows the aromatics of binding seg-*Correspondence: dadougherty@caltech.edu
4 Lab address: http://www.bioc.cam.ac.uk/uto/lummis.html
5 Lab address: http://www.cco.caltech.edu/wlester/hal.html
6 Lab address: http://www.its.caltech.edu/wdadgrp/ments B–D in four members of the superfamily. Previ-
ous studies show that in the nACh [6] and 5-HT3 [7]
receptors, a tryptophan residue on binding segment B
makes a unique contribution to agonist binding through
a cation-π interaction [8, 9]. In MOD-1, another seroto-
nin-gated channel that is highly homologous to the
5-HT3 receptor, the binding segment B residue is a tyro-
sine. Surprisingly, serotonin does not make a cation-π
interaction with this binding segment B tyrosine in
MOD-1, but instead the neurotransmitter reorients so
as to make a cation-π interaction with a tryptophan on
binding segment C [10]. This is consistent with the
strong bias toward Trp in cation-π interactions [11].
There is, however, no tryptophan in the GABAC re-
ceptor that aligns with any predicted binding site resi-
due. Instead, the GABAC receptor binding site is rich
in tyrosines, and the residues aligned with the binding
segment B or C tryptophans are both tyrosines. In the
present work, we show that the B segment residue,
Tyr198, contributes a cation-π interaction to agonist
binding in the GABAC receptor. Given the relatively low
homology of GABAC to the better characterized nAChR
and 5-HT3 receptor, this binding anchor point will be
valuable in developing detailed structural models of
both GABAC and the related GABAA receptors.
Results and Discussion
From our previous studies of Trp residues in other Cys-
loop receptors [6, 7, 10], a straightforward strategy for
evaluating a possible cation-π interaction has emerged.
A fluorine substituent is deactivating in the cation-π
interaction, and the effects of multiple fluorine substitu-
tions are additive. A large, systematic decrease in ago-
nist affinity with increasing fluorination provides com-
pelling evidence for a cation-π interaction. The small
steric size and reluctance to participate in hydrogen
bonding interactions further make fluorine an ideal sub-
stituent.
Implementing this strategy for tryptophan residues
was straightforward. The series Trp; 5-F-Trp; 5,7-F2-Trp;
5,6,7-F3-Trp; and 4,5,6,7-F4-Trp was introduced at the
site of interest, and agonist potency was measured. A
comparable strategy for evaluating a tyrosine faces an
additional complication. In addition to potentially mak-
ing a cation-π interaction, tyrosine has the ability to par-
ticipate as a hydrogen bond donor. Fluorination of tyro-
sine would modulate the hydrogen bonding ability of
the ring. Fluorination also progressively lowers the pKa
of the tyrosine OH, such that highly fluorinated tyro-
sines are expected to be ionized at physiological pH
[12]. Both factors would complicate any analysis of
binding to a cationic ligand. Thus, it is preferable to
evaluate fluorinated phenylalanine derivatives, pro-
vided that phenylalanine functions adequately in place
of tyrosine at the site of interest.
As shown in Table 1, the Tyr198Phe mutant is fully
functional and displays only a modest shift in EC50.
Thus, further modifications of the Tyr198Phe mutant
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994Figure 1. The Cys-Loop Superfamily of Receptors
(A) Model of the GABAC receptor extracellular domain showing two
subunits. The ligand binding site lies between these subunits and
is formed by residues from binding segments A–C on the principal
subunit and binding segments D–F on the adjacent/complemen-
tary subunit.
(B) Amino acids that contribute to the aromatic box of the agonist
binding site in four different Cys-loop receptors, including designa-
tion of the appropriate binding segment. Those residues that have
a cation-π interaction with agonist are in bold.
(C) Structures of the different natural agonists that activate the re-
ceptors in (B).
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otor and has a very similar cation-π binding ability.
Table 1. Substituent Effects on Cation-π Interactions and GABAC EC50
Aromatic Ring Cation-π Binding Energy (kcal/mol)a EC50 (M) [Hill Coeff.]
Phenol (Tyr) 26.9b 2.1c ± 0.2 [1.6 ± 0.2, n = 4]
Benzene (Phe) 27.1b 9.5c ± 1 [1.6 ± 0.1, n = 4]
Methoxybenzene 28.6 6.6 ± 2 [1.6 ± 0.2, n = 4]
Fluorobenzene 22.0b 34 ± 7 [1.9 ± 0.3, n = 4]
1,3-difluorobenzene 17.1 1700 ± 400 [1.4 ± 0.2, n = 4]
1,2,3-trifluorobenzene 12.9 8400 ± 1000 [1.5 ± 0.1, n = 4]
a 6-31G**//6-31G** calculated binding energy of Na+ to the appropriate aromatic. Calculations were done on the simple aromatic ring, that is,
benzene to model Phe, phenol to model Tyr, and so on. The EC50 measurements are for incorporation of the full Phe/Tyr analog.
b [6].
c Obtained by nonsense suppression.
sume that the subtle mutations introduced here to resi-can be employed to probe the agonist binding site. As
such, 4-F-Phe, 3,5-F2-Phe, and 3,4,5-F3-Phe (Figure 2)
were incorporated at position 198. Another interesting
tyrosine analog is 4-MeO-Phe (or, equivalently, O-Me-
Tyr), as it removes the hydrogen bond donor from the
side chain of Tyr but retains the hydrogen bond accep-
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iigure 2. Structures of the Side Chains of the Natural and Unnatural
mino Acids Used in This StudyAll the side chains shown in Figure 2 were incorpo-
ated into position 198 of the GABAC receptor using the
n vivo nonsense suppression methodology developed
reviously, and the resulting mutant receptors were ex-
mined using voltage clamp analysis [13, 14]. All the
eceptors showed concentration-dependent GABA-
nduced whole-cell responses, and typical responses
ith F3-Phe are shown in Figure 3. As summarized in
able 1, perturbations of the aromatic side chain at po-
ition 198 had significant and interpretable conse-
uences. Progressive fluorination does indeed lead to
arge, progressive increases in EC50. As in previous
tudies [6, 7, 10], we wished to have a semiquantitative
redictor of cation-π binding ability for our modified
ide chains. For this, we turned to ab initio, quantum
echanical calculations of the binding of a probe cat-
on, Na+, to the appropriate ring. The precise identity of
he cation is not critical, as it has been shown repeat-
dly that the trend in cation-π binding energies is the
ame regardless of the cation [8, 9]. That trend is the
ssue here.
The results of Table 1 are most easily appreciated
ith reference to the plot of Figure 4. Here we plot the
ation-π binding energy versus log EC50 (scaled to wild-
ype), which transforms the experimental data to a
cale that is proportional to energy. As in previous
tudies with Trp, an excellent linear correlation is seen
cross the series of Phe derivatives. The consistency
f the trend and the substantial magnitude of the effect
eave no doubt that the ammonium ion of GABA forms
significant cation-π interaction with the side chain of
esidue 198 of the GABAC receptor. We note that the
unctional measurement we report, EC50, reflects con-
ributions from agonist binding and gating. However, as
n previous studies [6, 7, 10], we consider it safe to as-
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995Figure 3. Exemplar of Concentration-Response Data Obtained from
Two-Electrode Voltage Clamp Recordings from a Single Xenopus
Oocyte Expressing the 198-F3-Phe Mutantdues that directly define that agonist binding site and
presumably contact the ligand result in modulation of
ligand affinity, not receptor gating.
The wild-type Tyr residue was not included in the lin-
ear fit of Figure 4. Including it does not meaningfully
impact the fit, but the presentation of Figure 4 high-
lights an interesting observation. The EC50 for Tyr is
w4-fold lower than what would be expected based on
the trend line for the other residues. While the effect
is small, it does suggest that additional interactions to
Tyr198 may be important. We propose that the en-
hanced affinity for tyrosine reflects the participation of
the OH of Tyr198 as a hydrogen bond donor to a back-
bone carbonyl, a water molecule, or to GABA itself. It
is well established that involving the OH of a Tyr as a
hydrogen bond donor measurably enhances the cat-
ion-π binding ability of the ring [15]. However, the com-
puted cation-π binding ability of Table 1 and Figure 4 is
for the unperturbed ring. In this model, Tyr and Phe are
predicted to have essentially identical cation-π binding
abilities, and so the deviation from the EC50 trend line
seen with Tyr suggests a significant hydrogen bond ef-
fect. Alternatively, the agonist could be making a favor-
able electrostatic interaction with the phenolic oxygen,
also an effect that our small probe cation Na+ would not
sense. However, 4-MeO-Phe has a comparable oxygen
substituent, and the fact that it lies on the line of Figure
4 makes this second explanation less likely.
The GABAC receptor becomes the fourth member of
the Cys-loop superfamily of receptors for which a linear
“fluorination plot” has revealed a cation-π interaction.
For three receptors, it is an aligned residue on binding
segment B: Trp149 of the nAChR; Trp183 of the 5-HT3
receptor; and Tyr198 of the GABAC receptor. In the
fourth example, MOD-1, the cation-π interaction has
moved to a location on binding segment C, Trp226. Fig-
ure 5 compares these fluorination plots; MOD-1 is not
shown, as its results are essentially superimposable on
the 5-HT3 line, both receptors binding serotonin to a
tryptophan.
Our measure of the cation-π interaction binding abil-
ity of an aromatic system is the computed binding en-
ergy of a Na+ cation to the ring in the gas phase. This
primarily probes the electrostatic component of the
cation-π interaction, because a small, focused cation
like Na+ has a very small polarizability. The full cation-π
interaction does include polarization effects (such as
ion-induced dipole and dipole-induced dipole interac-
tions) and van der Waals/dispersion forces, especially
with “organic” cations such as the neurotransmittersFigure 4. A Cation-π Interaction in the GABAC Receptor
Plot of the data of Table 1, and a linear fit. All EC50 values are
scaled to wild-type. The wild-type tyrosine residue is not included
in the fit. If it were, the linear fit would give: y = 6.5 − 0.225x; R =
0.974.evaluated here. However, earlier work showed that
when varying the aromatic partner in the interaction and
keeping the cation constant, the trend in the cation-π
interaction results exclusively from variation in the elec-
trostatic component of the binding [16]. This justifies
the fluorination plots we have used here and elsewhere.
It is interesting that the quantitative impact of pro-
gressive fluorination, as judged by Na+ binding, is
essentially the same whether indole or benzene is the
base aromatic. This is evidenced by the nearly perfect
vertical alignment of the various data points in Figure
5. Thus, while indole (Trp) is intrinsically a stronger cat-
ion-π binder than benzene (Phe), the modulation of the
electrostatic component of the cation-π interaction by
fluorination is the same for the two systems. This al-
lows a direct comparison of the three different agonists
considered here: ACh, serotonin, and GABA. Intrinsi-
cally, electrostatic interactions are stronger for smaller,
more focused ions [8, 9]. In the present context, that
means we would anticipate that the primary ammonium
(RNH3+) agonists serotonin and GABA should respond
more strongly to variation in the electrostatic compo-
nent of the cation-π interaction than the quaternary am-
monium (RN[CH3]3+) agonist ACh. Indeed, we find that
the slopes of the plots in Figure 5 are steeper for sero-
tonin and GABA than for ACh, indicating a stronger
electrostatic component to the cation-π interaction.
Note that a quaternary ammonium like ACh is much
more polarizable than the simpler cations, and so non-
electrostatic aspects of the cation-π interaction are ex-
pected to be more important for ACh.
In conclusion, our data show a strong correlation be-
tween the cation-π binding abilities of tyrosine analogs
and receptor function, indicating a cation-π interaction
between the primary ammonium of GABA and the side
chain of tyrosine at position 198 of the GABAC receptor.
These results provide further evidence of the power of
the unnatural amino acid methodology to provide chemi-
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996Figure 5. “Fluorination Plots” for the nACh, 5-HT3, and GABAC Re-
ceptors
Note that the x axis has been offset, so that the parent, nonfluori-
nated amino acid (Trp for nACh and 5-HT3; Phe for GABAC) is given
a value of zero. The actual values are 32.6 kcal/mol for Trp and 26.9
kcal/mol for Phe (Table 1). Progressive fluorination diminishes the
cation-π binding ability. All EC50 values are ratios to the wild-type
value, so all three data sets have a point at (0,0). For nACh, 5-HT3,
and GABAC receptors, respectively, the slopes (R values) are
−0.097 (0.994); −0.170 (0.997); and −0.222 (0.979). The slight differ-
ence in slope for GABAC here versus Figure 4 reflects the fact that
4-MeO-Phe is not included in this fit.
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This is the first demonstration, to our knowledge, that
tyrosine can form such a cation-π interaction between
an agonist and a neurotransmitter receptor protein. By
locating the ammonium of GABA close to Tyr198, this
study establishes that this amino acid is indeed in the
binding pocket, providing an important anchor point for
efforts to dock GABA in its binding site. As there are
now an increasing number of models of the binding
sites of Cys-loop receptors, an accurate knowledge of
the correct orientation of the neurotransmitter is impor-
tant both for understanding its mechanism of action
and for drug development efforts.
Experimental Procedures
Mutagenesis and Preparation of cRNA and Oocytes
Mutant GABAC receptor subunits were developed using pcDNA3.1
(Invitrogen, Abingdon, UK) containing the complete coding se-
quence for the ρ1 GABAC receptor subunit kindly provided by D.S.
Weiss (University of Alabama at Birmingham). The tyrosine codon
at position 198 was replaced by TAG as previously described [7].
Mutagenesis reactions were performed using the Kunkel method,
and confirmed by DNA sequencing [17]. Wild-type and mutant re-
ceptor subunit coding sequences were then subcloned into
pGEMHE [18]. This was linearized with Nhe1 (New England Biolabs,
Ipswich, MA) and cRNA was synthesized using the T7 mMESSAGE
mMACHINE kit (Ambion, Austin, TX). Oocytes from Xenopus laevis
were prepared and maintained as described previously [14].
Synthesis of tRNA- and dCA-Amino Acids
Unnatural amino acids were chemically synthesized as nitroverat-
ryloxycarbonyl (NVOC)-protected cyanomethyl esters and coupled
to the dinucleotide dCA, which was then enzymatically ligated to
1
1
1
14-mer THG73 tRNACUA as detailed previously [14]. Immediately
rior to coinjection with mRNA, tRNA-amino acids were depro-
ected by photolysis. Typically 5 ng mRNA and 25 ng tRNA-amino
cids were injected into Stage V-VI oocytes in a total volume of 50
l. For control experiments, mRNA was injected (1) in the absence
f tRNA and (2) with the THG73 74-mer tRNA. Experiments were
erformed 24–72 hr postinjection.
haracterization of Mutant Receptors
ABA-induced currents were recorded from individual oocytes
sing an OpusXpress system (Molecular Devices Axon Instru-
ents, Union City, CA) as previously described [19]. Briefly, experi-
ents were performed at 22–25°C. GABA (Sigma, St. Louis, MO)
as freshly prepared daily, diluted in ND96, and delivered to cells
ia a computer-controlled perfusion system. Glass microelectrodes
ere backfilled with 3 M KCl and had a resistance of approximately
M. The holding potential was –60 mV. EC50 values were deter-
ined from dose-response data using PRISM software (GraphPad,
an Diego, CA).
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